GoLiver Therapeutics

About:

GoLiver Therapeutics is specialized in the development of Innovative Therapy Medicines to meet an unmet urgent medical.

Top Investors: Government of France

Description:

GoLiver Therapeutics is a spin-off of Inserm and the University of Nantes (CRTI UMR1064, ITUN, University Hospital of Nantes), specializing in the development of Innovative Therapy Drugs (MTI) to meet an urgent medical need not met in transplantation.

Total Funding Amount:

1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nantes, Pays de la Loire, France

Founded Date:

2017-01-01

Contact Email:

secretariat(AT)golivertx.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2021-03-25

IPO Status:

Private

Industries: